Skip to content

Clinical trials

Panuveitis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Panuveitis Country / region: United States Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20073
20082
20092
20104
20123
20131
20142
20151
20161
20173
20181
20222
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated8
Unknown status2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Clearside Biomedical, Inc.5
Lux Biosciences, Inc.3
XOMA (US) LLC3
Novartis2
Johns Hopkins University1
Mallinckrodt1
Massachusetts Eye Research and Surgery Institution1
National Eye Institute (NEI)1
Regeneron Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Panuveitis27
Uveitis23
Uveitis, Posterior22
Uveitis, Intermediate21
Uveitis, Anterior8
Behcet Syndrome2
Choroidal Effusions2
Inflammation2
Macular Edema2
Ophthalmia, Sympathetic2

Trials

Showing 26 to 27 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.